1.16
3.33%
-0.04
After Hours:
1.15
-0.01
-0.86%
Ekso Bionics Holdings Inc stock is traded at $1.16, with a volume of 54,922.
It is down -3.33% in the last 24 hours and down -3.33% over the past month.
Ekso Bionics Holdings Inc designs, develops and sells exoskeleton technology used in healthcare and industrial markets. The wearable exoskeletons are to be worn over clothes and controlled by a trained operator to augment human strength, endurance, and mobility. The company's segments are EksoHealth and EksoWorks. All of the company's operations are held in the United States. The EksoHealth segment which derives majority revenue designs, engineers, manufactures and sells exoskeletons for applications in the medical markets. The EksoWorks segment designs, engineers, manufactures, and markets exoskeleton devices to allow able-bodied users to perform difficult repetitive work for extended periods. The regions company operates in are the Americas, EMEA, and APAC.
See More
Previous Close:
$1.20
Open:
$1.17
24h Volume:
54,922
Relative Volume:
0.64
Market Cap:
$24.24M
Revenue:
$18.28M
Net Income/Loss:
$-15.20M
P/E Ratio:
-0.9587
EPS:
-1.21
Net Cash Flow:
$-12.21M
1W Performance:
-4.13%
1M Performance:
-3.33%
6M Performance:
-14.71%
1Y Performance:
+58.25%
Ekso Bionics Holdings Inc Stock (EKSO) Company Profile
Name
Ekso Bionics Holdings Inc
Sector
Industry
Phone
510-984-1761
Address
101 GLACIER POINT, SAN RAFAEL
Ekso Bionics Holdings Inc Stock (EKSO) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Oct-14-16 | Initiated | SunTrust | Buy |
Ekso Bionics Holdings Inc Stock (EKSO) Latest News
Human Augmentation Market Report 2024 Highlighting Rising - openPR
Speech Pathology Services Market Outlook: 2023 the Year on a Positive Note | Benchmark Therapies Inc, Dynatronics Corporation, Ekso Bionics Holdings Inc, GF health Products, Inc – Cauverynews - Cauverynews
Ekso Bionics (NASDAQ:EKSO) Now Covered by Analysts at StockNews.com - Defense World
TNR, The Niche Research says :Global Wearable Robotic Exoskeleton Market is Expected to Expand at a CAGR of 44.3% (2024 to 2034). This Growth Projection Covers Segments Including Type, Application, Functionality, Technology, End User,Region - Yahoo Finance
Esperion CEO Sheldon Koenig sells shares worth over $26k By Investing.com - Investing.com Canada
Esperion CEO Sheldon Koenig sells shares worth over $26k - Investing.com
BofA Securities Downgrades Esperion Therapeutics Inc. (ESPR) to an Underperform from a Neutral - Knox Daily
Stock Performance Spotlight: Esperion Therapeutics Inc. (ESPR) Ends the Day at 1.76, Down by -7.85 - The Dwinnex
EMINOVA HOLDINGS INTERNATIONAL signed a 1.5 M USD FUND RAISING AGREEMENT for "BIOREL KIDS FUN FOAM’ product - EIN News
National Bank of Canada FI Raises Stake in Esperion Therapeutics, Inc. (NASDAQ:ESPR) - Defense World
Ekso Bionics (NASDAQ:EKSO) Earns Hold Rating from Analysts at StockNews.com - Defense World
Speech Pathology Services Market Outlook: 2022 the Year on a Positive Note | Benchmark Therapies Inc, Dynatronics Corporation, Ekso Bionics Holdings Inc, GF health Products, Inc – Cauverynews - Cauverynews
Human Augmentation Market 2024 Growth factor – Samsung Electronics Co. Ltd.,Google LLC,Ekso Bionics Holdings Inc.,Garmin Ltd. – Cauverynews - Cauverynews
Ekso Bionics (NASDAQ:EKSO) Coverage Initiated by Analysts at StockNews.com - Defense World
Medical Exoskeleton Market to grow by USD 2.87 billion from 2024-2028, driven by rising spinal cord injury cases, AI-powered report- Technavio - The Malaysian Reserve
Medical Exoskeleton Market to grow by USD 2.87 billion from 2024-2028, driven by rising spinal cord injury cases, AI-powered report- Technavio - Lelezard
Medical Exoskeleton Market to grow by USD 2.87 billion from 2024-2028, driven by rising spinal cord injury cases, AI-powered report- Technavio - Yahoo Finance
Ekso Bionics Holdings Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits - Quantisnow
Ekso Bionics Holdings Inc (EKSO) Becoming More Attractive for Investors - Knox Daily
Medical Exoskeleton Market Statistical Forecast, Trade - openPR
StockNews.com Begins Coverage on Ekso Bionics (NASDAQ:EKSO) - Defense World
SEC Form 424B4 filed by Ekso Bionics Holdings Inc. - Quantisnow
Ekso Bionics Announces Pricing of $6.0 Million Underwritten Public Offering - ForexTV.com
Ekso Bionics Announces Pricing of $6.0 Million Underwritten Public Offering - StockTitan
Ekso Bionics Announces Pricing of $6.0 Million Underwritten Public Offering - GlobeNewswire
Investors Give Ekso Bionics Holdings, Inc. (NASDAQ:EKSO) Shares A 26% Hiding - Simply Wall St
Ekso Bionics (EKSO) Addressable Market to Grow on CMS Update - Yahoo Finance
Lawsuit for Investors in Ekso Bionics Holdings, Inc. (NASDAQ: EKSO) Shares Announced by Shareholders Foundation - Newswire
Ekso Bionics (NASDAQ:EKSO) Receives New Coverage from Analysts at StockNews.com - Defense World
Ekso Bionics Holdings Inc (EKSO) rating initates by SunTrust - Knox Daily
Ekso Bionics Announces Receipt of Initial CMS Reimbursement for Ekso Indego Personal - GlobeNewswire
Ekso Bionics secures Medicare reimbursement for exoskeleton - Investing.com India
Ekso Bionics secures Medicare reimbursement for exoskeleton - Investing.com
Ekso Bionics Announces Receipt of Initial CMS Reimbursement for Ekso Indego Personal - StockTitan
Ekso Bionics Holdings (FRA:23E2) 14-Day RSI : 35.05 (As of Aug. 20, 2024) - GuruFocus.com
Ekso Bionics Announces Receipt of Initial CMS Reimbursement for Ekso Indego Personal - Yahoo Finance
EKSO (Ekso Bionics Holdings) LT-Debt-to-Total-Asset : 0.19 (As of Jun. 2024) - GuruFocus.com
EKSO (Ekso Bionics Holdings) Debt-to-Revenue : 0.34 (As of Jun. 2024) - GuruFocus.com
EKSO (Ekso Bionics Holdings) Short-Term Debt & Capital Leas - GuruFocus.com
EKSO (Ekso Bionics Holdings) Total Current Liabilities : $7.70 Mil (As of Jun. 2024) - GuruFocus.com
EKSO (Ekso Bionics Holdings) Growth Rank : 7 (As of Aug. 18, 2024) - GuruFocus.com
EKSO (Ekso Bionics Holdings) Total Liabilities : $14.93 Mil (As of Jun. 2024) - GuruFocus.com
EKSO (Ekso Bionics Holdings) Long-Term Debt : $4.35 Mil (As of Jun. 2024) - GuruFocus.com
Ekso Bionics Holdings (LTS:0IFR) 3-Year Dividend Growth Rat - GuruFocus.com
Ekso Bionics Holdings (STU:23E2) Future 3-5Y Total Revenue Growth Rate : 25.06 (As of Aug. 17, 2024) - GuruFocus.com
Ekso Bionics Holdings (STU:23E2) Financial Strength : 4 (As of Jun. 2024) - GuruFocus.com
Ekso Bionics Holdings (LTS:0IFR) 14-Day RSI : 38.39 (As of Aug. 17, 2024) - GuruFocus.com
Ekso Bionics Holdings (STU:23E2) EV-to-Revenue : 0.94 (As of Aug. 17, 2024) - GuruFocus.com
Ekso Bionics Holdings (LTS:0IFR) Altman Z-Score : -12.37 (As of Aug. 17, 2024) - GuruFocus.com
EKSO (Ekso Bionics Holdings) Float Percentage Of Total Shar - GuruFocus.com
EKSO (Ekso Bionics Holdings) EV-to-Revenue : 1.04 (As of Aug. 15, 2024) - GuruFocus.com
Ekso Bionics Holdings Inc Stock (EKSO) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):